Beijing Chunlizhengda Reports Voting Results and Attendance at Extraordinary General Meeting

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ) just unveiled an update.

Beijing Chunlizhengda Medical Instruments Co., Ltd. held an extraordinary general meeting (EGM) on 29 December 2025 in Beijing, convened by its board and chaired by chairman Shi Wenling, with all directors in attendance either in person or by telephone. The meeting, which complied with PRC law, Hong Kong Listing Rules and the company’s articles, adopted a combination of internet voting via the Shanghai Stock Exchange trading system for A shareholders and onsite poll voting, with its auditor Wuyige Certified Public Accountants LLP acting as scrutineer; out of 383,568,500 issued shares, 382,191,649 were eligible to vote after excluding treasury shares, and 229,835,580 voting shares were represented by 39 shareholders and proxies (38 A-share holders and one H-share holder), with no shareholders required to abstain or having indicated plans to vote against any resolutions.

The most recent analyst rating on (HK:1858) stock is a Hold with a HK$17.50 price target. To see the full list of analyst forecasts on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H stock, see the HK:1858 Stock Forecast page.

More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H

Beijing Chunlizhengda Medical Instruments Co., Ltd. is a joint stock company incorporated in the PRC and listed in Hong Kong (Stock Code: 1858). The company issues both A shares and H shares and operates under the regulatory frameworks of the PRC and the Hong Kong Listing Rules, with its shareholder base split between domestic A-share investors and overseas H-share investors.

Average Trading Volume: 1,732,109

Technical Sentiment Signal: Buy

Current Market Cap: HK$9.03B

Find detailed analytics on 1858 stock on TipRanks’ Stock Analysis page.